• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新氨基糖苷类抗生素福提霉素A和B。IV. 福提霉素A与其他氨基糖苷类药物的体外研究。

Fortimicins A and B, new aminoglycoside antibiotics. IV. In vitro study of fortimicin A compared with other aminoglycosides.

作者信息

Girolami R L, Stamm J M

出版信息

J Antibiot (Tokyo). 1977 Jul;30(7):564-70. doi: 10.7164/antibiotics.30.564.

DOI:10.7164/antibiotics.30.564
PMID:19409
Abstract

The in vitro antimicrobial activity of fortimicin A, the most active member of the fortimicin complex, was compared with that of amikacin, gentamicin, sagamicin and tobramycin against 352 strains of Enterobacteriaceae and other medically significant organisms. Against most of these organisms fortimicin and amikacin had comparable levels of antimicrobial activity, generally slightly less than that of gentamicin, sagamicin or tobramycin. Fortimicin had relatively weak activity against Pseudomonas aeruginosa strains. Fortimicin shows many of the characteristics of other aminoglycoside antibiotics: (i) improved activity at alkaline pH, (ii) rapid, bactericidal action, (iii) reduced activity with increasing inoculum levels, and (iv) synergistic activity with penicillin against enterococci. The activity of fortimicin was compared to that of gentamicin, tobramycin and amikacin against a group of 95 naturally occurring, antibiotic-resistant Gram-negative bacilli other than Pseudomonas. The organisms were isolated from clinical sources and selected primarily for gentamicin resistance by the sensitivity disc test. Fortimicin showed excellent activity against this group of organisms. At a concentration of 6.2 mcg/ml, fortimicin inhibited the most strains (92.6%) followed by amikacin (90.5%), gentamicin (23.2%) and tobramycin (8.4%).

摘要

将福提霉素复合物中活性最强的成员福提霉素A的体外抗菌活性,与丁胺卡那霉素、庆大霉素、紫苏霉素和妥布霉素针对352株肠杆菌科细菌及其他具有重要医学意义的微生物的抗菌活性进行了比较。针对大多数这些微生物,福提霉素和丁胺卡那霉素具有相当的抗菌活性水平,总体上略低于庆大霉素、紫苏霉素或妥布霉素。福提霉素对铜绿假单胞菌菌株的活性相对较弱。福提霉素具有其他氨基糖苷类抗生素的许多特性:(i)在碱性pH值下活性增强;(ii)快速杀菌作用;(iii)随着接种量增加活性降低;(iv)与青霉素对肠球菌具有协同活性。将福提霉素与庆大霉素、妥布霉素和丁胺卡那霉素针对一组95株除假单胞菌外自然产生的耐抗生素革兰氏阴性杆菌的活性进行了比较。这些微生物从临床来源分离得到,主要通过药敏纸片试验选择对庆大霉素耐药的菌株。福提霉素对这组微生物显示出优异的活性。在浓度为6.2 mcg/ml时,福提霉素抑制的菌株最多(92.6%),其次是丁胺卡那霉素(90.5%)、庆大霉素(23.2%)和妥布霉素(8.4%)。

相似文献

1
Fortimicins A and B, new aminoglycoside antibiotics. IV. In vitro study of fortimicin A compared with other aminoglycosides.新氨基糖苷类抗生素福提霉素A和B。IV. 福提霉素A与其他氨基糖苷类药物的体外研究。
J Antibiot (Tokyo). 1977 Jul;30(7):564-70. doi: 10.7164/antibiotics.30.564.
2
Compound A49759, the 3-O-demethyl derivative of fortimicin A: in vitro comparison with six other aminoglycoside antibiotics.化合物A49759,福提霉素A的3-O-去甲基衍生物:与其他六种氨基糖苷类抗生素的体外比较
Antimicrob Agents Chemother. 1980 Nov;18(5):773-9. doi: 10.1128/AAC.18.5.773.
3
Comparative antimicrobial activity of O-demethylfortimicin A, a derivative of fortimicin A.福提霉素A的衍生物O-去甲基福提霉素A的抗菌活性比较
Antimicrob Agents Chemother. 1980 Nov;18(5):766-72. doi: 10.1128/AAC.18.5.766.
4
1-N HAPA gentamicin B, a new aminoglycoside active against gentamicin resistant isolates--activity compared to other aminoglycosides.
J Antibiot (Tokyo). 1978 May;31(5):385-93. doi: 10.7164/antibiotics.31.385.
5
3-0-demethyl fortimicin A: in vitro activity and interpretive zone standards for disk diffusion susceptibility tests.3 - O - 去甲基福提霉素A:纸片扩散法药敏试验的体外活性及解释性抑菌圈标准
Eur J Clin Microbiol. 1984 Dec;3(6):531-7. doi: 10.1007/BF02013613.
6
Aminoglycosides plus beta-lactams against gram-negative organisms. Evaluation of in vitro synergy and chemical interactions.氨基糖苷类药物与β-内酰胺类药物联合用于抗革兰氏阴性菌。体外协同作用及化学相互作用的评估。
Am J Med. 1986 Jun 30;80(6B):126-37. doi: 10.1016/0002-9343(86)90490-0.
7
Fortimicin A: collaborative in vitro susceptibility. Comparison with amikacin and gentamicin against 11,840 clinical bacterial isolates.福提霉素A:体外协同药敏性。与阿米卡星和庆大霉素针对11840株临床分离菌的比较。
Antimicrob Agents Chemother. 1979 Dec;16(6):823-8. doi: 10.1128/AAC.16.6.823.
8
Changes in resistance to aminoglycoside antibiotics of different bacterial strains isolated during the period 1978 to 1983. Netilmicin as alternative therapy.1978年至1983年期间分离出的不同菌株对氨基糖苷类抗生素耐药性的变化。奈替米星作为替代疗法。
Chemioterapia. 1985 Dec;4(6):439-44.
9
In vitro comparison of aminoglycoside activities and their synergistic action with piperacillin.氨基糖苷类药物活性及其与哌拉西林协同作用的体外比较
Infection. 1985 Jan-Feb;13(1):39-42. doi: 10.1007/BF01643620.
10
Susceptibility of current clinical isolates of Pseudomonas aeruginosa and enteric gram-negative bacilli to amikacin and other aminoglycoside antibiotics.铜绿假单胞菌和肠道革兰氏阴性杆菌的当前临床分离株对阿米卡星和其他氨基糖苷类抗生素的敏感性。
J Infect Dis. 1976 Nov;134 SUPPL:S394-90.

引用本文的文献

1
Central composite design for optimizing istamycin production by Streptomyces tenjimariensis.用中心复合设计优化棘孢小单孢菌产生棘霉素。
World J Microbiol Biotechnol. 2024 Sep 9;40(10):316. doi: 10.1007/s11274-024-04118-4.
2
Evaluation of fortimicin antibiotic combinations against MDR Pseudomonas aeruginosa and resistome analysis of a whole genome sequenced pan-drug resistant isolate.评价妥布霉素抗生素组合对多药耐药铜绿假单胞菌的作用及全基因组测序泛耐药分离株的耐药组分析。
BMC Microbiol. 2024 May 14;24(1):164. doi: 10.1186/s12866-024-03316-2.
3
The genus as a model microorganism for bioactive natural product discovery.
该属作为生物活性天然产物发现的模式微生物。
RSC Adv. 2020 Jun 8;10(35):20939-20959. doi: 10.1039/d0ra04025h. eCollection 2020 May 27.
4
Astonishing diversity of natural surfactants: 4. Fatty acid amide glycosides, their analogs and derivatives.天然表面活性剂的惊人多样性:4. 脂肪酸酰胺糖苷、其类似物及衍生物。
Lipids. 2005 Jul;40(7):641-60. doi: 10.1007/s11745-005-1427-8.
5
Compound A49759, the 3-O-demethyl derivative of fortimicin A: in vitro comparison with six other aminoglycoside antibiotics.化合物A49759,福提霉素A的3-O-去甲基衍生物:与其他六种氨基糖苷类抗生素的体外比较
Antimicrob Agents Chemother. 1980 Nov;18(5):773-9. doi: 10.1128/AAC.18.5.773.
6
Comparative antimicrobial activity of O-demethylfortimicin A, a derivative of fortimicin A.福提霉素A的衍生物O-去甲基福提霉素A的抗菌活性比较
Antimicrob Agents Chemother. 1980 Nov;18(5):766-72. doi: 10.1128/AAC.18.5.766.
7
In vitro and in vivo antibacterial activity of KW1070, a new aminoglycoside antibiotic.新型氨基糖苷类抗生素KW1070的体外和体内抗菌活性
Antimicrob Agents Chemother. 1980 Feb;17(2):138-43. doi: 10.1128/AAC.17.2.138.
8
Antibacterial activity of fortimicin A compared with those of five other aminoglycosides, and factors affecting susceptibility tests.福提霉素A与其他五种氨基糖苷类药物的抗菌活性及影响药敏试验的因素
Antimicrob Agents Chemother. 1981 Jan;19(1):122-9. doi: 10.1128/AAC.19.1.122.
9
Synergistic activities of fortimicin A and beta-lactam antibiotics against Pseudomonas aeruginosa.福提霉素A与β-内酰胺类抗生素对铜绿假单胞菌的协同活性。
Antimicrob Agents Chemother. 1981 Jul;20(1):33-7. doi: 10.1128/AAC.20.1.33.
10
Synthesis of 3-O-demethylfortimicins.3-O-去甲基弗氏菌素的合成
Antimicrob Agents Chemother. 1980 Nov;18(5):761-5. doi: 10.1128/AAC.18.5.761.